These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1041 related articles for article (PubMed ID: 28112467)

  • 1. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park SW; Serruys PW; Park SJ
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):177-185. PubMed ID: 28112467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Cavalcante R; Sotomi Y; Zeng Y; Lee CW; Ahn JM; Collet C; Tenekecioglu E; Suwannasom P; Onuma Y; Park SJ; Serruys PW
    Heart; 2017 Mar; 103(6):428-433. PubMed ID: 27651390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
    Takagi H; Ando T; Umemoto T;
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):697-709. PubMed ID: 28799701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
    Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
    Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease.
    Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kajimoto K; Kasai T; Tamura H; Okazaki S; Isoda K; Yamamoto T; Amano A; Daida H
    Heart Vessels; 2016 Sep; 31(9):1424-9. PubMed ID: 26412228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study.
    Jeong YJ; Ahn JM; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park H; Kang DY; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ; Park DW
    J Am Heart Assoc; 2021 Jul; 10(14):e019834. PubMed ID: 34238026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.
    Sotomi Y; Onuma Y; Cavalcante R; Ahn JM; Lee CW; van Klaveren D; de Winter RJ; Wykrzykowska JJ; Farooq V; Morice MC; Steyerberg EW; Park SJ; Serruys PW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary Artery Bypass Grafting Versus Drug-Eluting Stents Implantation for Previous Myocardial Infarction.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Zeng Y; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    Am J Cardiol; 2016 Jul; 118(1):17-22. PubMed ID: 27181565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Park DW; Ahn JM; Park H; Yun SC; Kang DY; Lee PH; Kim YH; Lim DS; Rha SW; Park GM; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ;
    Circulation; 2020 May; 141(18):1437-1446. PubMed ID: 32223567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Mahmoud AN; Elgendy IY; Mentias A; Saad M; Ibrahim W; Mojadidi MK; Nairooz R; Eshtehardi P; David Anderson R; Samady H
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):541-552. PubMed ID: 28296170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.